1. Ishitsuka K, Tamura K. Human T-cell leukaemia virustype I and adult T-cell leukaemia-lymphoma. TheLancet Oncology. 2014;15(11):e517-e526. [DOI:10.1016/S1470-2045(14)70202-5]

2. Yamagishi M, Ishida T, Miyake A, et al. Retroviraldelivery of promoter-targeted shRNA induces long-term silencing of HIV-1 transcription. MicrobesInfect. Apr 2009;11(4):500-8. doi:10.1016/j.micinf.2009.02.003 [DOI:10.1016/j.micinf.2009.02.003]

3. Setoyama M, Katahira Y, Kanzaki T. Clinicopathologicanalysis of 124 cases of adult T‐cell leukemia/lymphoma with cutaneous manifestations: thesmouldering type with skin manifestations hasa poorer prognosis than previously thought. TheJournal of dermatology. 1999;26(12):785-790. [DOI:10.1111/j.1346-8138.1999.tb02093.x]

4. Sakihama S, Karube K. Genetic Alterations in AdultT-Cell Leukemia/Lymphoma: Novel Discoverieswith Clinical and Biological Significance. Cancers(Basel). May 12 2022;14(10)doi:10.3390/cancers14102394 [DOI:10.3390/cancers14102394]

5. Shimoyama M. Diagnostic criteria and classificationof clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group(1984-87). Br J Haematol. Nov 1991;79(3):428-37.doi:10.1111/j.1365-2141.1991.tb08051.x [DOI:10.1111/j.1365-2141.1991.tb08051.x]

6. Katsuya H, Yamanaka T, Ishitsuka K, et al.Prognostic index for acute- and lymphoma-typeadult T-cell leukemia/lymphoma. J Clin Oncol.May 10 2012;30(14):1635-40. doi:10.1200/JCO.2011.38.2101 [DOI:10.1200/JCO.2011.38.2101]

7. Marçais A, Suarez F, Sibon D, Frenzel L, Hermine O,Bazarbachi A. Therapeutic options for adult T-cellleukemia/lymphoma. Current oncology reports.2013;15(5):457-464. [DOI:10.1007/s11912-013-0332-6]

8. Taylor J, Xiao W, Abdel-Wahab O. Diagnosis andclassification of hematologic malignancies on thebasis of genetics. Blood. Jul 27 2017;130(4):410- [DOI:10.1182/blood-2017-02-734541]

9. Kogure Y, Kataoka K. Genetic alterations in adultT-cell leukemia/lymphoma. Cancer Sci. Sep 2017;108(9):1719-1725. doi:10.1111/cas.13303 [DOI:10.1111/cas.13303]

10. Kataoka K, Shiraishi Y, Takeda Y, et al. Aberrant PD-L1 expression through 3'-UTR disruption in multiplecancers. Nature. Jun 16 2016;534(7607):402-6.doi:10.1038/nature18294 [DOI:10.1038/nature18294]

11. Tsukasaki K, Tanosaki S, DeVos S, et al. Identifyingprogression-associated genes in adult T-cell leukemia/lymphoma by using oligonucleotide microarrays. IntJ Cancer. May 10 2004;109(6):875-81. doi:10.1002/ijc.20028 [DOI:10.1002/ijc.20028]

12. Takeuchi M, Miyoshi H, Ohshima K. Tumormicroenvironment of adult T-cell leukemia/lymphoma. J Clin Exp Hematop. 2021;61(4):202-209. doi:10.3960/jslrt.21007 [DOI:10.3960/jslrt.21007]

13. Hicklin DJ, Wang Z, Arienti F, Rivoltini L, ParmianiG, Ferrone S. beta2-Microglobulin mutations,HLA class I antigen loss, and tumor progression inmelanoma. J Clin Invest. Jun 15 1998;101(12):2720-9. doi:10.1172/JCI498 [DOI:10.1172/JCI498]

14. Momburg F, Moller P, Moldenhauer G, HammerlingGJ. Loss of HLA-A,B,C in colorectal carcinomais related to the degree of de-differentiation. JImmunogenet. Apr-Jun 1986;13(2-3):195-9.doi:10.1111/j.1744-313x.1986.tb01101.x [DOI:10.1111/j.1744-313X.1986.tb01101.x]

15. Kataoka K, Nagata Y, Kitanaka A, et al. Integratedmolecular analysis of adult T cell leukemia/lymphoma. Nat Genet. Nov 2015;47(11):1304-15.doi:10.1038/ng.3415 [DOI:10.1038/ng.3415]

16. Ohshima K. Molecular Pathology of Adult T-CellLeukemia/Lymphoma. Oncology. 2015;89 Suppl1:7-15. doi:10.1159/000431058 [DOI:10.1159/000431058]

17. Kogure Y, Kameda T, Koya J, et al. Whole-genomelandscape of adult T-cell leukemia/lymphoma.Blood. Feb 17 2022;139(7):967-982. doi:10.1182/blood.2021013568 [DOI:10.1182/blood.2021013568]

18. Chaib-Mezrag H, Lemacon D, Fontaine H, et al. Taximpairs DNA replication forks and increases DNAbreaks in specific oncogenic genome regions. MolCancer. Sep 4 2014;13:205. doi:10.1186/1476-4598-13-205 [DOI:10.1186/1476-4598-13-205]

19. Moles R, Bai XT, Chaib-Mezrag H, Nicot C. WRN-targeted therapy using inhibitors NSC 19630 and NSC617145 induce apoptosis in HTLV-1-transformedadult T-cell leukemia cells. J Hematol Oncol. Nov 92016;9(1):121. doi:10.1186/s13045-016-0352-4 [DOI:10.1186/s13045-016-0352-4]